Decrease in Racial Disparities in the Staging Evaluation for Prostate Cancer After Publication of Staging Guidelines

Journal of Urology

Volumn 178, Issue 1, 2007, Pages 82-87

  Abraham, Nitya ^a   Wan, Fei ^b   Montagnet, Chantal ^b,d   Wong, Yu Ning ^e   Armstrong, Katrina ^b,c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Veterinary Medicine   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

African Americans; neoplasm staging; practice guidelines; prostate; prostatic neoplasms

Indexed keywords

AGED; ARTICLE; BONE SCINTISCANNING; CANCER INCIDENCE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION; RACE DIFFERENCE; RETROSPECTIVE STUDY;

AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; GUIDELINE ADHERENCE; HUMANS; MALE; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 34250175490     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.035     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106
2. Ries L., Eisner M., Kosary C., Hankey B., Miller B., Clegg L., et al. SEER Cancer Statistics Review, 1975-2002 (2005), National Cancer Institute, Bethesda
3. Roach M.I., Tempany C., Choyke P., Anscher M., Bluth E., Kawashima A., et al. Expert Panel on Radiation Oncology-Prostate Work Group (ROP) and Urologic Imaging. Pretreatment Staging Prostate Cancer (1995), American College of Radiology, Reston 11
4. Middleton R., Thompson I., and Austenfeld M. AUA Clinical Practice Guidelines: Report on the Management of Clinically Localized Prostate Cancer (1995), American Urological Association, Baltimore
5. Baker L., Hanks G., Gershenson D., Kantoff P., Lange P., Logothetis C., et al. NCCN prostate cancer practice guidelines. Oncology 10 (1996) 265
6. Grimshaw J.M., and Russell I.T. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342 (1993) 1317
7. Cooperberg M., Lubeck D., Grossfeld G., Mehta S., and Carroll P. Contemporary trends in imaging test utilization for prostate cancer staging: data from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 168 (2002) 491
8. Kindrick A.V., Grossfeld G.D., Stier D.M., Flanders S.C., Henning J.M., and Carroll P.R. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database. J Urol 160 (1998) 2102
9. Silber J. Multivariate matching and bias reduction in the surgical outcomes study. Med Care 39 (2001) 1048
10. Oesterling J.E., Martin S.K., Bergstralh E.J., and Lowe F.C. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269 (1993) 57
11. Levran Z., Gonzalez J.A., Diokno A.C., Jafri S.Z., and Steinert B.W. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?. Br J Urol 75 (1995) 778
12. Chybowski F.M., Keller J.J., Bergstralh E.J., and Oesterling J.E. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 145 (1991) 313
13. Saigal C.S. The economic costs of early stage prostate cancer. Pharmacoeconomics 20 (2002) 869
14. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94 (2002) 334
15. Shavers V., Brown M., Potosky A., Klabunde C., Davis W., Moul J., et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med 19 (2004) 146
16. Underwood III W., Demonner S., Ubel P., Fagerlin A., Sanda M., and Wei J. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 171 (2004) 1504
17. Williams M.L., Hill G., and Jackson M. The impact of an acute myocardial infarction guideline and pathway on racial outcomes at a university hospital. Ethn Dis 16 (2006) 653
18. Owen Jr. W.F., Szczech L.A., and Frankenfield D.L. Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine. J Natl Med Assoc 94 (2002) 83S
19. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969
20. Carlin B., and Andriole G. The natural history, skeletal complications and management of bone metastases in patients with prostate carcinoma. Cancer 88 (2000) 2989